With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Comprehensive gene expression analysis of IDH1/2 mutant biliary cancers (BC)

The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies

The landscape of DNA damage response (DDR) pathway in colorectal cancer (CRC)

Somatic alterations of NF1 in colorectal cancer

Molecular features of gliomas with high tumor mutational burden

Characterization of NRG1 gene fusion events in solid tumors

Comprehensive molecular analysis of Microsatellite-Stable (MSS) Tumors with High Mutational Burden in gastrointestinal (GI) cancers

Molecular correlates of PD-L1 expression in patients (pts) with gastroesophageal cancers

Alterations in targetable molecular pathways are enriched in KRAS wild-type (WT) pancreatic cancer (PC)

Is there a genomic fingerprint of Radon induced lung cancer? Comparison of genomic alterations in lung cancer specimens from high and low Rn zones